[Definitions and clinical experimentation of anti-osteoarthritis agents/chondro-protectors. Survey among private rheumatologists].
Through osteoarthritis is the most common rheumatic disease its fundamental medicinal therapy(s) remain(s) still to be discovered. Definitions of the terms anti-osteoarthritic or chondroprotective agents vary according to the conceptual ideas in presence. They are discussed. In order to know the view point of private rheumatologists, a survey has been realised. 63 rheumatologists answered a questionnaire which included three parts: the first one, semantic, concerned definitions of anti-osteoarthritic and chondroprotective drugs and their respective place in therapeutic; a questionnaire of methodology was then exploring conception and organisation of clinical trials to assess such drugs in osteoarthritis; finally questions were asked on feasibility of such trials. The results are presented and discussed below.
Maheu
E
E
Institut Technique pour l'Etude du Médicament (ITEM), Le Kremlin-Bicêtre.
Dropsy
R
R
D002357:Cartilage Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D012219:Rheumatology; D011795:Surveys and Questionnaires; D009626:Terminology as Topic
Définitions et expérimentation clinique des anti-arthrosiques/chondroprotecteurs. Enquête auprès des rhumatologues libéraux.